JCR Pharmaceuticals Co., Ltd.

We create treatments that go beyond rare disease
to solve the world's most complex healthcare challenges

Press Releases

2026.11.02 FY2026 Second Quarter Results Briefing Session - Script
2026.11.02 FY2026 Second Quarter Results Briefing Session - Movie
2026.10.29 FY2026-Q2 Financial Report (Jul. 1-Sep. 30, 2026)
2026.10.29 FY2026 Second Quarter Results Briefing Session - Material

2026.10.26 Notice Regarding Our Response to the PHP Vulnerability
2026.09.18 Integrated Report 2026
2026.06.23 Notice of Resolutions Passed at The 51st Ordinary General Meeting of Shareholders
2026.06.03 Shareholders and Investors Please click here for details regarding the convocation of The 51st Ordinary General Meeting of Shareholders.

Patients and Families

Shareholders and Investors

As a Global Specialty Pharma
in the Rare Disease Field

We are one of the few biopharmaceutical companies in Japan
that drive the entire value chain-from research and development to manufacturing and commercialization.
With strong R&D and manufacturing capabilities, we have continued to push the limits of possibility.
Rare diseases present ongoing challenges, yet we remain committed to bringing hope to more patients.
At JCR, we will keep turning new treatment possibilities into reality.

01

Our Commitment to Rare Diseases
02

Advancing with Unique Biotechnologies and Expertise
03

A Relentless Pursuit of Manufacturing Excellence

Who We Are

JCR Pharmaceuticals is one of the few biopharmaceutical companies in Japan that provides an integrated value chain spanning research, development, manufacturing, and commercialization.

ResearchandDevelopment

At JCR Pharma, we leverage our proprietary biotechnology and accumulated expertise to develop high‑value, innovative therapies.
By delivering new treatment options, we aim to contribute to better health and the future of medicine.